A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China
Clinical trial NCT07456774 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07456774
- Sponsor
- Novo Nordisk A/S
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2026-02-13
- Primary completion
- 2026-08-31
- Enrollment
- 100000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.